FDA approves first-of-its-kind cholesterol pill
The FDA approved Lipfendra, the first oral PCSK9 inhibitor by Merck, marking a new way to treat hypercholesterolemia with a daily pill.
The FDA approved Lipfendra, the first oral PCSK9 inhibitor by Merck, marking a new way to treat hypercholesterolemia with a daily pill.
What's Your Reaction?
